ST7L Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid repeated freeze-thaw cycles.
Lead Time
Typically, we can ship your order within 1-3 business days of receiving it. Delivery times may vary depending on the shipping method and destination. For specific delivery time estimates, please contact your local distributor.
Synonyms
ST7L; ST7R; Suppressor of tumorigenicity 7 protein-like; ST7-related protein
Target Names
ST7L
Uniprot No.

Target Background

Gene References Into Functions

Target Background

ST7L (Suppression of Tumorigenicity 7 Like) has been implicated in various cellular processes, particularly in cancer development.

  • MIR31HG: Overexpression of MIR31HG enhances the expression of ST7L by acting as a sponge for miR-575, thereby suppressing tumorigenicity in hepatocellular carcinoma (HCC). (PMID: 30176933)
  • miR-378: This microRNA functions as an oncogene by directly downregulating ST7L mRNA and protein levels. (PMID: 28902356)
  • miR-23b: Studies have revealed significant roles for miR-23b and ST7L in the progression of hepatocellular carcinoma. (PMID: 28518144)
  • miR-23a: In epithelial ovarian cancer cells, miR-23a suppresses ST7L expression by binding to its 3'UTR. ST7L, in turn, inhibits proliferation, migration, and invasion of these cancer cells. (PMID: 27537390)
  • miR-24: This microRNA acts as a direct regulator of ST7L. (PMID: 23142218)
Database Links

HGNC: 18441

OMIM: 617640

KEGG: hsa:54879

UniGene: Hs.201921

Protein Families
ST7 family
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What are the primary indicators researchers should collect when studying antibody responses in community settings?

Multiple indicators should be collected to provide a more complete picture of antibody responses in community settings. Based on research from King's College London, combining self-reported symptoms, participant suspicion of infection, and antibody testing results offers more reliable data than any single measure alone. Their study demonstrated that relying on a single indicator (such as external test results or self-reported symptoms) may lead to under or overestimation of prevalence . The most complete approach involves:

  • Collection of detailed symptom information using validated symptom algorithms

  • Documentation of participant suspicion of infection

  • Results of any external testing participants may have received

  • Laboratory or point-of-care antibody testing

  • Follow-up testing to account for potential antibody waning

This multi-indicator approach allows researchers to develop algorithms that maximize case history identification rather than relying on single measures that may provide a false sense of certainty .

How reliable are at-home antibody testing methods for research studies?

Home antibody testing using lateral flow devices can be a practical approach for community-based research studies, but comes with important considerations. Research from King's College London found that participants could successfully perform these tests when provided with illustrated instructions and access to responsive support . Their study showed:

  • High proportion of participants (90%+) returned valid test results

  • Participants could effectively photograph and submit results for research team verification

  • Minimal issues when proper instructions and support were provided

How should researchers account for the temporal dynamics of antibody responses in study design?

Accounting for temporal dynamics of antibody responses is critical in research study design. Evidence from COVID-19 studies indicates antibody levels may decline significantly over time, particularly after mild infections . Key considerations include:

  • Antibodies may decline over 3+ months post-infection, especially on lateral flow devices, affecting sensitivity

  • Mild infections produce more inconsistently detected antibody responses than severe cases

  • Some individuals may not produce detectable anti-spike antibodies despite infection

For optimal study design, researchers should:

  • Document the timing of suspected infection and any symptoms

  • Include repeated antibody testing at strategic intervals

  • Consider supplementing antibody testing with T-cell response testing for tracking long-term immunity

  • Implement mathematical modeling to account for potential antibody waning when estimating prevalence

The King's College study noted that testing occurring at least three months after symptom onset may miss cases due to antibody waning, suggesting that single time-point antibody testing has limitations for retrospective case identification .

How should researchers interpret discordance between different COVID-19 indicators in cohort studies?

When faced with discordant indicators (symptoms, participant suspicion, and antibody test results), researchers should implement structured analysis approaches. The King's College study provides valuable insights on this challenge :

  • Analyze each indicator's sensitivity and specificity against available reference standards

  • Create intersectional groups based on combinations of indicators

  • Report proportions testing positive within each intersectional group

Their analysis revealed that participant suspicion significantly modified the probability of testing positive within symptom categories. For example, 49% of participants with positive symptom algorithm scores and "definite" suspicion tested antibody positive, compared to only 13% of those with positive symptom scores but "unsure" suspicion . This demonstrates that analyzing the intersections of multiple indicators provides more nuanced understanding than any single indicator alone.

What are the optimal antibody testing approaches for community-based cohort studies?

Based on research evidence, optimal antibody testing approaches for community-based cohort studies should balance practicality, acceptability, and accuracy . Key recommendations include:

  • Select testing platforms with high specificity (>98%) to minimize false positives, particularly important in large population studies with expected low prevalence

  • Consider the trade-off between laboratory-based testing (higher accuracy but lower participation) versus home-based testing (potentially lower accuracy but higher participation)

  • Implement quality control measures such as photographic verification of test results

  • Provide clear illustrated instructions and responsive support for home testing

  • Train research staff to interpret results consistently

The King's College London study demonstrated that home-based lateral flow cassette testing can be implemented successfully in community cohorts when accompanied by appropriate support and verification systems, with minimal invalid results .

How can researchers develop integrated algorithms to classify COVID-19 exposure in the absence of definitive testing?

Developing integrated classification algorithms represents an important methodological approach when definitive contemporaneous testing is unavailable. Based on the King's College London experience, researchers should consider :

  • Implementing validated symptom algorithms (such as the COVID Symptom Study algorithm)

  • Weighting participant suspicion as a modifier of symptom-based classification

  • Incorporating antibody testing as an objective measure while acknowledging potential false negatives due to waning

  • Analyzing the sensitivity and specificity of different algorithm combinations against available reference standards

Their research demonstrated that combining these indicators provided improved classification compared to single measures. For example, having core COVID-19 symptoms alone yielded a 14% probability of positive antibody testing, while having core symptoms plus definite suspicion yielded a 38% probability of positive antibody testing .

What are the key limitations of antibody testing for retrospective case identification?

Researchers should be aware of several critical limitations when using antibody testing for retrospective case identification :

  • Sensitivity limitations: Antibody levels may wane over time, especially after mild infection

  • Biological variation: A small percentage of people do not produce detectable antibodies despite infection

  • Timing challenges: The optimal window for antibody detection varies based on test platform and severity of infection

  • Test technology considerations: Lateral flow devices typically have lower sensitivity than laboratory-based assays

The King's College London study found evidence suggesting antibody test sensitivity declines when testing occurs months after infection. Among participants who reported previous antibody testing elsewhere, only 15% were positive on their study antibody test, compared with 24% who reported positive results on earlier external antibody tests .

What future methodological approaches might address current limitations in antibody research?

Based on current research, several promising approaches could address existing limitations :

  • Integration of T-cell response testing alongside antibody testing to better track long-term immunity

  • Development of more sensitive point-of-care antibody tests optimized for detecting waned responses

  • Implementation of statistical approaches that account for time-dependent sensitivity decline

  • Creation of standardized algorithms combining multiple indicators with weighted importance

The King's College London researchers suggest that augmenting antibody testing with T-cell response testing may be possible in the future to better track long-term immunity . They also emphasize the importance of developing algorithms that maximize case history identification rather than relying on single measures which may provide a false sense of certainty.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.